Immunology Webinars
Follow a curation of discoveries and updates in immunology focusing on immune responses to infectious disease, structure and function, and developments in the defense against infection by watching and engaging in these webinars.
Show More
-
JUL 20, 2017 | 10:00 AM
DATE: July 20, 2017TIME: 10:00am PT, 1:00pm ETPart 1 - Daniel Beacham: Case study showing how CyQUANT Direct Cell Proliferation and Fluo-4 calcium imaging assays were us...
APR 11, 2023 | 8:00 AM
C.E. CREDITS
Date: April 11, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Duchenne muscular dystrophy is caused by mutations in the dystrophin encoding DMD gene that disrupt the reading frame. M...
NOV 16, 2022 | 7:00 PM
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
NOV 12, 2020 | 10:00 AM
Date: November 12, 2020 Time: 10:00am (PST), 1:00pm (EST) Fc receptor based affinity chromatography is a new emerging field of Fc functionality analytics. FcRn affinity columns separate anti...
MAR 07, 2019 | 7:00 AM
DATE: March 7, 2019TIME: 4:00pm CET PSCs represent an important tool in a wide range of applications, including basic research, disease...
NOV 30, 2021 | 8:00 AM
Date: November 30, 2021 Time: 8:00am (PDT), 11:00am (EDT) The DNA Vector Lab at the German Cancer Research Center (DKFZ) has developed Nano-S/MARt (nS/MARt), a novel DNA Vector platform that...
DEC 01, 2021 | 8:00 AM
Date: December 01, 2021 Time: 8:00am (PDT), 11:00am (EDT) Discover how taking a holistic approach can help simplify and improve your cell culture media process workflows. In a discussion wit...
NOV 13, 2019 | 12:00 PM
DATE: November 13, 2019TIME: 12:00pm PT NK cells play a major role in immune surveillance and in the early immune response to cancer and infections. Beneficial anti-tumor respo...
JUN 26, 2024 | 12:00 PM
Mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma, is characterized by malignant T-cell skin infiltration leading to inflammation and skin barrier defects. To effecti...
JUN 16, 2021 | 8:00 AM
Date: June 16, 2021 Time: 8:00am PDT The MACSima™ Imaging Platform is the only complete solution for ultrahigh-content imaging of hundreds of markers, allowing you to understand the tu...
MAY 31, 2017 | 9:00 AM
DATE: May 31, 2017TIME: 9:00AM PDT, 12:00PM ETAlthough more remains to be learnt, great advances have recently been made in the understanding of the molecular & genetic bases of dis...
JUL 26, 2023 | 8:00 AM
Differences in how users gate populations within experiments are major sources of variability in flow...
NOV 29, 2018 | 7:00 AM
DATE: November 29, 2018TIME: 15:00pm WET, 07:00am PST O vírus da Hepatite C (HCV) é uma infeção mundial, que...
MAY 11, 2021 | 8:00 AM
DATE: May 11, 2021 TIME: 8:00am PDT T cells are most important from basic research to therapeutic approaches and play a pivotal role in many diverse application fields such as basic immu...
AUG 23, 2023 | 8:00 AM
Do you want to bring your CAR NK cell and Treg cell research into clinical applications? Watch this webinar and explore Miltenyi Biotec’s solutions to advance CAR NK cell and Treg-base...
APR 19, 2022 | 10:00 AM
Date: April 19, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) Once upon a time, there were three public health labs. These labs were busy serving their states when, out of nowhere, a...
OCT 31, 2023 | 9:00 AM
Gene therapy holds potential for treating neurological diseases by delivering genetic information into specific cell types. However, selective and efficient targeting of cell types remains c...
JUN 17, 2020 | 1:30 PM
Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
DEC 12, 2017 | 10:00 AM
DATE: December 12, 2017TIME: 10:00AM PTSince their discovery, dendritic cells (DCs) have demonstrated a central role in the development of effective immune responses. Their unique abili...
